InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: longfellow95 post# 258786

Wednesday, 01/15/2020 10:05:04 AM

Wednesday, January 15, 2020 10:05:04 AM

Post# of 700225
longfellow, I didn’t have time to post but I also have interest in Cobra Bio. As Doclogic said, Cobra Bio certainly has direct relevance to Northwest Bio.

"This acquisition is central to Cognate's strategy to build on its existing offerings and create an enterprise platform for life cycle management of cell and gene therapy products, accelerating the availability of new technologies to patients that need them most," J. Kelly Ganjei, Cognate’s CEO, said in a release. "Cobra is a well-established leader in the development and manufacture of a variety of DNA and viral vectors that our current and prospective clients urgently need. “The combined Cognate-Cobra expertise, infrastructure, and geographical footprint immediately positions both businesses to better respond to current and future market needs more quickly, effectively, and comprehensively,” Ganjei continued.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News